Renal Association Working Group on Tolvaptan in ADPKD · Otsuka UK using the reporting mechanism...

Preview:

Click to see full reader

Citation preview

1

Renal Association Working Group on Tolvaptan in ADPKD

2

http://www.nice.org.uk/guidance/TA358
https://www.scottishmedicines.org.uk/SMC_Advice/Advice/1114_15_tolvaptan_Jinarc/tolvaptan_Jinarc
https://www.scottishmedicines.org.uk/SMC_Advice/Advice/1114_15_tolvaptan_Jinarc/tolvaptan_Jinarc

3

4

https://clinicaltrials.gov/ct2/show/NCT02160145
http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196569.pdf
http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196569.pdf
https://c-path.org/programs/pkd/regulatory-successes/
https://c-path.org/programs/pkd/regulatory-successes/

5

evidence

Evidence

http://www.niddk.nih.gov/health-information/health-communication-programs/nkdep/lab-evaluation/gfr-calculators/adults-si-unit-ckd-epi/Pages/default.aspx
http://www.niddk.nih.gov/health-information/health-communication-programs/nkdep/lab-evaluation/gfr-calculators/adults-si-unit-ckd-epi/Pages/default.aspx
http://www.niddk.nih.gov/health-information/health-communication-programs/nkdep/lab-evaluation/gfr-calculators/adults-si-unit-ckd-epi/Pages/default.aspx

6

risk

http://www.mayo.edu/research/documents/pkd-center-adpkd-classification/doc-20094754?_ga=1.42938278.2046346149.1449053926
http://www.mayo.edu/research/documents/pkd-center-adpkd-classification/doc-20094754?_ga=1.42938278.2046346149.1449053926
http://www.mayo.edu/research/documents/pkd-center-adpkd-classification/doc-20094754?_ga=1.42938278.2046346149.1449053926

7

PKD1

PKD2

PKD1

PKD2

8

9

10

11

12

13

14

15

16

17

Recommended

Nephrologie in der Hausarztpraxis - stgag.ch · Neues aus der Nephrologie •Tolvaptan bei ADPKD –Sinnvoll bei Patienten mit rascher Progression –Frühzeitige prognostische Evaluation!
Documents
Design and evaluation of tolvaptan solid dispersions … · Design and evaluation of tolvaptan solid dispersions using hot-melt extrusion and spray drying technique – A comparative
Documents
Autosomal Dominant Polycystic Kidney disease (ADPKD) & Pyelonephritis
Documents
Nuevos Tratamientos Para El ADPKD
Documents
Samsca (tolvaptan) - Accessdata FDA - Food and Drug Administration
Documents
MEDICATION GUIDE JYNARQUE (jin-AR-kew) (tolvaptan) Tablets
Documents
QC-Titrate / PC-Titrate
Documents
Rapport om ADPKD fra Dansk Nefrologisk Selskab (2012)nephrology.dk/Publikationer/ADPKD-rapport endelig version 21.11.12... · At opdatere selskabets rapport fra 2004(1) om tilbud
Documents
The Brussels Declaration on ADPKD - pkdinternational.org · The Brussels Declaration on ADPKD Autosomal dominant polycystic kidney disease (ADPKD) is a chronic, progressive, inherited
Documents
Renal Association Working Group on Tolvaptan in ADPKD · Mayo TKV < Single MR/CT Ht-TKV or PROPKD Eligib 30-89 IA-B 750m M a yo 1 C-E TKV >7soml for if 30-89 Repeat MR TKV =
Documents
Autosomal dominant polycystic kidney disease (adpkd)
Documents
University of Groningen ADPKD Messchendorp, Annemarie Lianne
Documents
Risk Evaluation and Mitigation Strategy (REMS) Document JYNARQUE(tolvaptan… · 2018-12-03 · Risk Evaluation and Mitigation Strategy (REMS) Document JYNARQUE(tolvaptan)REMS Program
Documents
QC-Titrate / PC-Titrate · Petrochemical Multiple methods and/or multiple samples are automated eliminating the use of labor intensive exchange units and utilizing a flexible, large
Documents
Tolvaptan treatment for severe neonatal autosomal-dominant ... · Background Severe neonatal autosomal-dominant polycystic kidney disease (ADPKD) is rare and easily confused with
Documents
Lab acid titrate
Documents
Back Titrate
Documents
Otsuka America Pharmaceutical, Inc. SAMSCA- tolvaptan tablet
Documents
Hyponatremia, Heart Failure, and the role of Tolvaptan (Samsca)
Documents
ADPKD Summit - Critical Path Institute Summit Agenda • Text “Addressing the Need for Clinical Endpoints in ADPKD”
Documents